Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917423 · ClinicalTrials.gov registry record
Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 147
- Enrollment target
NCT00917423: Completed study, sponsored by New York State Psychiatric Institute.
NCT00917423 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 147 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00917423 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
Study Summary
This study will determine the importance and the level of physical activity among women with anorexia nervosa, both during inpatient treatment and 1 year after hospital discharge.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2009-02 |
| Est. Completion | 2016-06 |
What the finished NCT00917423 record still lists
NCT00917423 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00917423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00917423 about?
NCT00917423 is a clinical study titled "Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa". This study will determine the importance and the level of physical activity among women with anorexia nervosa, both during inpatient treatment and 1 year after hospital discharge.
What is the current status of trial NCT00917423?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2009-02. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT00917423?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia